S Shu

3.2k citations

33 papers · 2.6k indexed · 1 hit paper · h-index 23

Impact in

Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 26
- Immunotherapy and Immune Responses 24
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 3
Biotechnology 10
- Cancer Research and Treatments 10

Co-authors: Alfred E. Chang James J. Mulé Steven A. Rosenberg Ting‐Chao Chou S A Rosenberg Gregory E. Plautz Bernard A. Fox Hirohisa Yoshizawa
Journals: The Journal of Immunology (13 papers)Journal of Clinical Oncology (2 papers)Journal of Immunotherapy (1 paper)Scientific Reports (1 paper)Journal of neurosurgery (1 paper)
Partner nations: United States Malaysia China

In The Last Decade

S Shu

31 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. 1993 · 692 citations

Peers

Countries citing papers authored by S Shu

Since Specialization

Citations

This map shows the geographic impact of S Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Shu more than expected).

Fields of papers citing papers by S Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Shu. The network helps show where S Shu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S Shu Line = papers co-authored together S Shu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Interfering with USP50 expression inhibits macrophage pyroptosis in sepsis-induced acute lung injury by degrading NLRP3 protein Scientific Reports ·Shanshan Hu, Jingjing Hu, S Shu, Chindu Chandran, Lu Wang	2025	0
2	Systemic T cell adoptive immunotherapy of malignant gliomas Journal of neurosurgery ·Gregory E. Plautz, Gene H. Barnett, David W. Miller, Bruce H. Cohen, Richard A. Prayson, John C. Krauss, Mark G. Luciano, Galen J. Bergsten, S Shu	1998	112
3	Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. Journal of Clinical Oncology ·Alfred E. Chang, Atsushi Aruga, Mark J. Cameron, Vernon K. Sondak, Daniel P. Normolle, Bernard A. Fox, S Shu	1997	120
4	Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes. PubMed ·Hiroshi Kagamu, Florian Leese, Ida Poonam Sletto, John C. Krauss, S Shu	1996	62
5	Seroepidemiologic Study of Cryptosporidium Infection in Children from Rural Communities of Anhui, China and Fortaleza, Brazil American Journal of Tropical Medicine and Hygiene ·Ipop Abdi Prabowo, B Naghavi, Leah J. Barrett, R. Fayer, S Shu, Jay McAuliffe, R. G. Holroyd, Richard L. Guerrant	1994	54
6	Molecular Genetic Interventions for Cancer Cold Spring Harbor Symposia on Quantitative Biology ·Gary J. Nabel, E G Nabel, Zhanqiu Yang, Bernard A. Fox, Gregory E. Plautz, Xiaohua Gao, Liyue Huang, S Shu, David J. Gordon, Alfred E. Chang	1994	4
7	Immunobiologic Effects of Cytokine Gene Transfer of the B16-BL6 Melanoma Archives of Otolaryngology - Head and Neck Surgery ·Scott E. Strome, John C. Krauss, Mark J. Cameron, K. Forslund, S Shu, Lemus Fonseca	1993	3
8	Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proceedings of the National Academy of Sciences ·Gary J. Nabel, E G Nabel, Zhiyong Yang, Bernard A. Fox, Gregory E. Plautz, Xiang Gao, Leaf Huang, S Shu, David Gordon, Alfred E. Chang Hit paper breakdown →	1993	692
9	Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells. PubMed ·Hirohisa Yoshizawa, Alfred E. Chang, S Shu	1992	49
10	A novel role for autologous tumour cell vaccination in the immunotherapy of the poorly immunogenic B16-BL6 melanoma Surgical Oncology ·James D. Geiger, Paul D. Wagner, S Shu, Alfred E. Chang	1992	23
11	Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2 The Journal of Immunology ·Hirohisa Yoshizawa, Alfred E. Chang, S Shu	1991	168
12	Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity. The Journal of Immunology ·S Shu, Ting‐Chao Chou, Keisuke Sakai	1989	71
13	Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity. The Journal of Immunology ·Ting‐Chao Chou, Yong-Mei Yuan, S Shu	1988	74
14	Lysis of primary hepatic tumours by lymphokine activated killer cells. Gut ·K. H. Hsieh, S Shu, Chun‐Sing Lee, Febrilina, C S Yang, King‐Jen Chang	1987	20
15	Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. The Journal of Immunology ·S Shu, Ting‐Chao Chou, Steven A. Rosenberg	1987	108
16	Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma. The Journal of Immunology ·Ta‐Hsu Chou, S Shu	1987	27
17	Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression. The Journal of Immunology ·L A Matis, S Shu, Eric S. Groves, S Zinn, Ta‐Hsu Chou, A M Kruisbeek, Maury Rosenstein, Steven A. Rosenberg	1986	37
18	In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells. The Journal of Immunology ·S Shu, Ting‐Chao Chou, Steven A. Rosenberg	1986	74
19	The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. The Journal of Immunology ·James J. Mulé, James C. Yang, S Shu, S A Rosenberg	1986	89
20	The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. The Journal of Immunology ·James J. Mulé, S Shu, S A Rosenberg	1985	241

About S Shu

S Shu is a scholar working on Immunology, Biotechnology, Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 33 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (18 papers), Cancer Research and Treatments (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Virus-based gene therapy research (6 papers), Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (1.2k citations), Biotechnology (189 citations), Genetics (569 citations) and Molecular Biology (815 citations). S Shu has collaborated with scholars based in United States, Malaysia and China. Frequent co-authors include Alfred E. Chang, James J. Mulé, Steven A. Rosenberg, Ting‐Chao Chou, S A Rosenberg, Gregory E. Plautz, Bernard A. Fox, Hirohisa Yoshizawa, Gary J. Nabel and Leaf Huang. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Journal of Immunotherapy, Scientific Reports and Journal of neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact